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Objectives We hypothesized that, in obese persons without comorbidities, cardiovascular responses to excess weight are
reversible during weight loss by either bariatric surgery or diet.
Background Obesity is associated with cardiac hypertrophy, diastolic dysfunction, and increased aortic stiffness, which are
independent predictors of cardiovascular risk.
Methods Thirty-seven obese (body mass index 40  8 kg/m2) and 20 normal-weight subjects (body mass index 21  2
kg/m2) without identifiable cardiac risk factors underwent cardiac magnetic resonance imaging for the assess-
ment of the left and right ventricles and of indexes of aortic function. Thirty of the obese subjects underwent
repeat imaging after 1 year of significant weight loss, achieved in 17 subjects by diet and in 13 subjects by bari-
atric surgery. Seven obese subjects underwent repeat imaging after 1 year of continued obesity.
Results Left and right ventricular masses were significantly increased, left ventricular diastolic function impaired, and
aortic distensibility reduced in the obese. Both diet and bariatric surgery led to comparable, significant de-
creases in left and right ventricular masses, end-diastolic volume, and diastolic dysfunction, and an increase in
aortic distensibility at all levels of the aorta, most pronounced distally (e.g., distal descending aorta 5.1  1.8
mm Hg1  103 before weight loss and 6.8  2.5 mm Hg1  103 after weight loss; p  0.001). No im-
provements were observed in continued obesity.
Conclusions Irrespective of method, 1 year of weight loss leads to partial regression of cardiac hypertrophy and to reversal of
both diastolic dysfunction and aortic distensibility impairment. These findings provide a potential mechanism for
the reduction in mortality seen with weight loss. (J Am Coll Cardiol 2009;54:718–26) © 2009 by the American
College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.02.086c
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rbesity, defined by a body mass index (BMI) 30 kg/m2,
s associated with an increased mortality rate, and even
reater risk is associated with a BMI of 35 kg/m2 (1).
entricular hypertrophy, diastolic dysfunction, and aortic
tiffness are present in obesity (2,3); there is a strong
elationship between left ventricular (LV) hypertrophy (4),
iastolic dysfunction (5), and all-cause mortality on the one
and, and between impairment of aortic elastic function and
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agnetic Resonance Research, and the †Department of Physiology, Anatomy, and
enetics, University of Oxford, Oxford, United Kingdom; and the ‡Department of
pper Gastrointestinal Surgery, Southampton, United Kingdom. This work has won
he 2008 American Heart Association Nutrition, Physical Activity, and Metabolism
oung Investigator Award. The study was supported by a grant from the Wellcome
rust and by the Oxford Partnership Comprehensive Biomedical Research Centre,
ith funding from the Department of Health’s NIHR Biomedical Research Centres
unding scheme.h
Manuscript received November 10, 2008; revised manuscript received January 26,
009, accepted February 17, 2009.ardiovascular events in healthy and diseased populations on
he other hand (6). Therefore, increased mortality in obesity
s likely to be related, at least in part, to the long-term
ardiovascular sequelae of increased body weight.
See page 727
Not only is obesity related to higher death rates, but also
growing body of evidence suggests that weight loss reduces
ong-term mortality (7). There is, however, little informa-
ion on the cardiovascular effects of weight loss in obese
ersons who have no other identifiable cardiovascular risk
actors. To investigate this important question, we under-
ook a study to assess the effects of substantial weight loss,
ver 1 year, on the cardiovascular changes present in obesity
er se, namely, in the absence of traditional cardiovascular
isk factors such as hypertension, diabetes mellitus, and
ypercholesterolemia. If LV hypertrophy, diastolic impair-
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August 18, 2009:718–26 Cardiovascular Effects of Weight Loss in Obesityent, and aortic stiffness are indeed reversible in such
ersons, that would suggest that important predictors of
ardiovascular risk can be positively influenced by weight
oss over 1 year. Such an observation would provide a
otential mechanism for the reduction in mortality associ-
ted with weight loss.
There are 2 main methods of weight loss: 1) dietary
ntervention; and 2) bariatric surgery. Surgical weight loss is
ow well established to confer better long-term weight
anagement than dietary weight loss and has been shown
o reduce long-term mortality (7). Therefore, the utilization
f bariatric surgery is rapidly increasing.
Despite this, no study to date has addressed the relative
eneficial effects of these different weight loss approaches on
ardiac and aortic structure and function. In view of this, the
econdary aim of this study was to compare the cardiovas-
ular effects of bariatric surgery and dietary weight loss.
ethods
thics and study cohort. The study was approved by the
ocal ethics committee, and informed written consent was
btained from each patient.
Fifty-seven subjects (37 obese, BMI 30 kg/m2, and 20
ormal weight controls, BMI 18.5 to 24.9 kg/m2) were
ncluded in the study. All subjects were screened for
dentifiable cardiac risk factors and excluded if they had a
istory of cardiovascular disease, current smoking, hyper-
ension, diabetes (fasting glucose level 6.7 mmol), a
asting total cholesterol level 6.5 mmol, or use of any
edications. All subjects had a normal 12-lead electrocar-
iogram, normal global and regional resting cardiac func-
ion on magnetic resonance (MR) imaging, and did not
erform3 sessions (defined as 30 min) of sweat-producing
xercise per week.
lood tests. Fasting blood tests for glucose, cholesterol,
eptin, insulin, free fatty acids, and C-reactive protein were
aken on the day of the scan. An estimate of insulin resistance
as calculated using the homeostasis model assessment of
nsulin resistance (HOMA-IR) equation (fasting insulin [U/
l]  fasting glucose [mmol/l] / 22.5) (8).
R imaging. All MR imaging scans for the assessment of
V and right ventricular (RV) mass, volumes, ejection
raction, diastolic function, and aortic distensibility were
erformed on a 1.5-T MR system (Siemens, Erlangen,
ermany). Images for ventricular volumes and diastolic
unction were acquired using a steady-state free precession
equence with an echo time of 1.5 ms, a repetition time of 3.0
s, in plane resolution 1.5  1.5 mm2, temporal resolution
7.84 ms, and a flip angle of 60°, as previously described (9).
ll imaging was cardiac gated and acquired during end-
xpiratory breath hold.
Indexes of aortic function were assessed using a retroga-
ed steady-state free precession cine sequence with the
ollowing parameters: temporal resolution 42 ms, echo time
.4 ms, field of view read 380 mm, in-plane resolution 1.97 im, and slice thickness 7 mm.
ortic cine images were acquired
n transverse planes at 3 levels as
reviously described (10); the
rossing of the pulmonary arch
hrough: 1) the ascending tho-
acic aorta; 2) the descending
horacic aorta; and 3) 12 cm be-
ow the right hemidiaphragm
erpendicular to the orientation
f the abdominal aorta. Brachial
rtery blood pressure was re-
orded during image acquisition
o provide pulse pressure.
isceral fat mass, body composition, and percentage
xcess weight. A single breath-hold, 5-slice, water-
uppressed T1-weighted turbo spin echo sequence centered
round L5 was acquired (11). Images were manually con-
oured for visceral fat volume. Percentage excess weight loss
as calculated according to the formula: percent excess
eight loss  (weight before  weight after [kg]/excess
ody weight before) where excess body weight (total body
eight  ideal body weight). Ideal body weight refers to the
eight if BMI  25 kg/m2. Bioelectrical impedance was used
o determine total body fat mass and body composition using
he Bodystat 1500 analyzer (Bodystat, Douglas, Isle of Man).
eight loss and continued obesity. Seventeen obese sub-
ects underwent a supervised low glycemic index diet, and 13
nderwent bariatric surgery (10 roux-en-Y gastric bypass, 3
aparoscopic adjustable gastric band). Follow-up was 390 
3 days. Neither group was enrolled in graded exercise
rograms. Seven additional obese subjects, initially enrolled
n the low glycemic index diet, who were unsuccessful in
osing weight, underwent repeat scanning after 1 year (378 
4 days) to determine the effects of continued obesity.
ata analysis. Image analysis for LV and RV volumes, mass,
nd diastolic function was performed using Siemens analytical
oftware (ARGUS). The short-axis stack was analyzed man-
ally, contouring endocardial and epicardial borders from base
o apex at end diastole and end systole to determine LV and
V mass (g) and volumes, as described (9). Left ventricular
ass was indexed to height, body surface area, and height2.7 to
nable more stringent allowance for obesity (12).
Manually contouring short-axis slices across the cardiac
ycle, volume time curves, diastolic peak filling rate, and
ime to peak filling rate, both normalized to end-diastolic
olume, were derived as described (13).
Aortic cross-sectional area in systole and diastole was
alculated using semiautomated in-house software within
atlab version 6.5 (Mathworks, Natick, Massachusetts),
hich shows a highly reproducible assessment of distensi-
ility (coefficient of variance 0.58%). Aortic distensibility
AD) was calculated according to the formula: AD ([Amax
Amin]/Amin)/(pulse pressure), where Amaxmaximal systolic
rea (mm2), and Amin  minimal diastolic area (mm
2). All
Abbreviations
and Acronyms
BMI  body mass index
HOMA-IR  homeostasis
model assessment of
insulin resistance
LV  left ventricle/
ventricular
MR  magnetic resonance
RV  right ventricle/
ventricularmages were analyzed blinded.
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Cardiovascular Effects of Weight Loss in Obesity August 18, 2009:718–26tatistical analysis. All statistics were performed using
PSS version 15 (SPSS, Chicago, Illinois). All results are
resented as mean  SD. All normally distributed datasets
established from Kolmogorov-Smirnov tests) were com-
ared using paired and unpaired t tests; non-normally
istributed datasets were compared using the Mann-
hitney U test and Wilcoxon signed-rank test where
pplicable. Differences were considered significant at p 
.05. Multivariate regression of data was also performed.
esults
nthropometric and serum characteristics. BASELINE.
ormal control and obese subjects were well matched for age
43 9 years vs. 44 8 years), height (169 6 cm vs. 169
Figure 1 MR Images Before and After Weight Loss
Magnetic resonance (MR) transverse T1-weighted turbo spin echo images at the le
and after (Post) diet-induced weight loss, demonstrating the substantial difference
Anthropomorphic and Serum CharacteristicsTable 1 Anthropomorphic and Serum Charac
Characteristic
Normal Weight
(n  20)
Body mass index, kg/m2 21.4 1.6
Weight, kg 60 7
Systolic blood pressure, mm Hg 115 9
Diastolic blood pressure, mm Hg 71 8
Waist measurement, inches 31 4
Hip measurement, inches 37 3
Visceral fat mass, dm3 2.4 1.2
Total fat mass, kg 17 3
Fasting glucose, mmol/l 4.9 0.4
Fasting cholesterol, mmol/l 5.0 0.8
Fasting insulin, m/l 3.0 2.8
Triglycerides, mmol/l 0.7 0.5
Fasting leptin, ng/ml 21 29
HOMA-IR score 0.7 0.6
C-reactive protein, mg/l 0.17 0.7
Free fatty acid levels, mmol/l 0.34 0.24
*p  0.05 obese versus normal. †p  0.05 before versus after weigh
HOMA-IR  homeostasis model assessment of insulin resistance.cm), sex (obese, 6 male and 24 female; normal weight, 5
ale and 15 female), systolic blood pressure, and cholesterol
Table 1). Diastolic blood pressure was significantly higher
n the obese subjects, but numerically, the difference was
mall and the measurements were within the normal range for
oth groups. Both waist and hip circumference were greater in
he obese cohort, as were waist/hip ratio, total fat mass, and
isceral fat mass. Serum leptin was 6.9 times higher in the
bese subjects. Although fasting glucose was higher in the
bese cohort, all measurements remained within the normal
anges. Fasting insulin and HOMA-IR were also higher in the
bese cohort, with the average still in the insulin-sensitive
ange. The C-reactive protein levels were 10-fold higher in
he obese cohort.
L5 before (Pre)
h visceral and subcutaneous fat mass.
tics
ese Before Weight Loss
(n  30)
Obese After Weight Loss
(n  30)
39.7 7.6* 32.2 5.3†
113 23* 92 18†
120 10 118 10
77 7* 75 10
46 7* 40 4†
49 6* 44 4†
7.3 2.9* 4.4 2.4†
50 19* 35 12†
5.3 0.7* 5.0 0.5†
5.1 0.7 4.9 0.8
7.8 6.9* 5.5 4.5
1.1 0.7* 0.7 0.8†
144 88* 87 77†
2.0 2.0* 1.2 1.0
1.9 3.1* 0.7 1.6†
0.58 0.31* 0.48 0.22vel of
in botteris
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August 18, 2009:718–26 Cardiovascular Effects of Weight Loss in ObesityFTER WEIGHT LOSS. After 1 year of weight loss (21 kg,
3% excess weight loss) (see Fig. 1 for example of cross-
ectional images), both visceral fat mass (by 40%) and total
at mass (by 30%) were reduced (pooled data from both
eight-loss groups). Waist and hip measures were reduced,
nd there was a 43% decrease in leptin. Systolic and diastolic
lood pressure were unchanged and so were fasting glucose,
nsulin, HOMA-IR values, and cholesterol. The C-reactive
rotein was reduced by 63%. Comparing surgical and
ietary methods, weight loss was higher in the surgical
roup (33  13 kg vs. 12  7 kg, p  0.01). However, the
ercentage excess weight loss was similar for both groups
surgical 61  22% vs. diet 48  42%, p  0.32).
ONTINUED OBESITY. After 1 year of continued obesity,
here was no significant change in BMI, fat mass, glucose,
holesterol, or blood pressure (data not shown).
V and RV characteristics. BASELINE. As expected, LV and
V masses and end-diastolic volume, both in absolute and
Left and Right Ventricular CharacteristicsTable 2 Left and Right Ventricular Characte
Characteristic
Normal W
(n  2
LV mass, g 87 2
LV mass indexed BSA, g/m2 50 1
LV mass:volume ratio 0.75 0
LV end-diastolic volume, ml 117 2
LV end-diastolic volume indexed height, ml/m 69 1
LV end-systolic volume, ml 37 1
LV stroke volume, ml 80 1
LV ejection fraction, % 69 5
Cardiac output, l/min 5.0 1
RV mass, g 25 1
RV mass indexed height, g/m 15 4
RV end-diastolic volume, ml 132 2
RV end-diastolic volume indexed height, ml/m 78 1
RV end-systolic volume, ml 51 1
RV stroke volume, ml 76 1
RV ejection fraction, % 61 6
*p  0.05 obese versus normal. †p  0.05 obese before weight loss
BSA  body surface area; LV  left ventricular; RV  right ventricu
A Comparison of the Effects of Dietary and SurgTable 3 A Comparison of the Effects of Diet
Ba
Change in LV mass, g
Change in LV EDV, ml
Change in RV mass, g
Change in RV EDV, ml
Change in ascending AD, mm Hg1  103
Change in proximal descending AD, mm Hg1  103
Change in abdominal AD, mm Hg1  103
Change in ventricular filling rate, ml/s 0*p  0.05 before versus after weight Loss. †p  0.05 surgical versus dietary
AD  aortic distensibility; EDV  end-diastolic volume; LV  left ventriculaeight-indexed terms, were greater in obesity (Table 2).
he LV mass/end-diastolic volume ratio and end-systolic
nd stroke volumes were also higher. The LV and RV
jection fractions were unchanged.
FTER WEIGHT LOSS. After weight loss, there was a 10%
eduction in absolute LV mass (Table 2) and indexed LV
ass (data not shown). The LV mass indexed to body
urface area did not change, namely, LV mass decreased in
roportion to body surface area after weight loss. The LV
nd-diastolic volume (absolute and indexed) was also signifi-
antly lower after weight loss. The LV mass/end-diastolic
olume ratio was unchanged and remained higher than in
ontrols. The LV end-systolic volume, stroke volume, and
ardiac output were reduced after weight loss, but heart rate
nd LV ejection fraction remained unchanged.
On pooled analysis, there was a 40% reduction in RV mass
absolute and height-indexed). The RV end-diastolic volume
as also significantly lower after weight loss, but changes in
s
Obese Before Weight Loss
(n  30)
Obese After Weight Loss
(n  30)
134 29* 121 16†
59 10* 58 10
0.89 0.16* 0.86 0.15
152 21* 141 21†
89 11* 83 11†
47 12* 42 10†
104 13* 99 14†
69 5 71 4
6.9 1.0* 6.3 1.2†
55 9* 33 7†
33 6* 20 3†
161 22* 153 23†
95 11* 90 11†
58 14* 56 12
102 15* 98 15
64 5 64 5
obese after weight loss.
eight Lossnd Surgical Weight Loss
bsolute Values
Normalized to Percent Excess
Weight Loss (102)
Cohort
13)
Diet Cohort
(n  17)
Bariatric Cohort
(n  13)
Diet Cohort
(n  17)
12* 10 11*† 2.7 3.7 2.9 2.5
14* 9 9* 1.7 3.2 3.4 4.2
12* 19 8* 6.9 5.1 4.9 3.4
17 10 18 0.3 3.2 4.8 10
2.7 0.7 2.3 2.1 4.0 2.6 11
1.9* 0.1 1.5*† 3.0 3.0 0.1 6.0
2.0* 1.8 1.8* 2.5 3.0 7.2 10
0.77* 0.77 0.84* 1.4 1.0 2.5 3.0ristic
eight
0)
0
0
.17
1
2
0
5
.0
7
6
5
4
9ical Wary a
A
riatric
(n 
19
13
25
4
1.2
1.9
1.5
.78weight loss.
r; RV  right ventricular.
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Cardiovascular Effects of Weight Loss in Obesity August 18, 2009:718–26V end-systolic and stroke volumes did not reach significance,
ikely due to higher variability of RV measurements. The RV
jection fraction was unchanged.
To assess the major determinants of the change in LV
ass with weight loss, single linear regression analysis was
rst performed. Changes in the following parameters sig-
ificantly correlated with LV mass reduction: BMI (R 
.73, p  0.001), body surface area (R  0.67, p  0.001),
ercentage excess weight loss (R  0.59, p  0.001),
isceral fat mass (R  0.58, p  0.001), end-diastolic
olume (R 0.45, p 0.016), and leptin (R 0.38, p 0.02).
tepwise multiple linear regression analysis of all data was
hen performed using a forced entry technique for the
ndependent variables. The multivariate model consisted of
V mass as the dependent variable and of independent
ariables that had significant relationships (taken here as p
0.05) with a change in LV mass on simple regression.
his analysis revealed change in BMI (  0.54, p  0.01)
nd change in LV end-diastolic volume ( 0.31, p 0.013) as
he only independent predictors of change in LV mass with
eight loss (overall R2  0.81, p  0.001).
IET VERSUS SURGERY. Both surgical and dietary groups
howed reductions in LV and RV mass (Table 3, Fig. 2).
eduction in absolute LV mass was greater for the surgical
roup, but when normalized to percentage excess weight
oss, it was similar for both groups. The RV mass and LV
nd-diastolic volume reductions were similar between the 2
roups. The RV end-diastolic volume was only reduced in
he diet group (p  0.03); changes after surgery did not
each significance (Fig. 2B), again likely because of the
reater variability of RV analysis.
ONTINUED OBESITY. After 1 year of continued obesity (Fig.
C), there was a 7% increase in absolute and height-indexed
V mass. The RV mass and LV and RV end-diastolic,
nd-systolic, and stroke volume were unchanged with contin-
ed obesity.
iastolic function. EFFECTOFOBESITY ANDWEIGHT LOSS.
besity subjects showed a 26% lower peak LV diastolic
lling rate compared with controls (3.6 0.8 ml/s vs. 4.6
.0 ml/s, p  0.001) (Fig. 3A), and time to peak filling rate
as 22% longer (196 40 ms vs. 161 44 ms, p 0.001).
n pooled group analysis, after weight loss, there was a 19%
ncrease in peak diastolic filling rate (3.6  0.8 ml/s vs.
.3  0.8 ml/s, p  0.001) and a 9% reduction in the time
o peak filling rate (178 28 ms vs. 196 40 ms, p 0.05)
Fig. 3A). Heart rate was similar between the normal weight
nd obese subjects before (63  7 beats/min vs. 66  9
eats/min) and after weight loss (64  9 beats/min). On
inear regression analysis, only the reduction in LV mass was
predictor of improvement in peak diastolic filling rate
R2  0.2, p  0.016). Both means of weight loss resulted
n similar improvements in diastolic function (Table 3, Fig. 4).
here was no difference in diastolic filling rate after 1 year
f continued obesity (Fig. 4).Figure 2 Ventricular Structure
Ventricular structure of (A) dietary weight loss, (B) bariatric surgery, and (C)
continued obesity. Open bars  pre-intervention; solid bars  post-intervention.
*p  0.05. LV  left ventricle; LVEDV  left ventricular end-diastolic volume; NS
 not significant (p  0.05); RV  right ventricle; RVEDV  right ventricular end-
diastolic volume.
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August 18, 2009:718–26 Cardiovascular Effects of Weight Loss in Obesityortic elastic function. BASELINE. Confirming our previ-
us study of baseline changes in obesity, performed on a
ifferent cohort (14), obese subjects had lower aortic dis-
ensibility at the level of the descending thoracic aorta
4.2  1.4 mm Hg1  103 vs. 5.7  1.9 mm Hg1 
03, p 0.002) and the abdominal aorta (5.1 1.8 vs. 7.4
2.6, p  0.001 (Fig. 3B). Distensibility of the ascending
orta was not significantly different (4.2  1.9 mm Hg1 
03 vs. 4.9  2.8 mm Hg1  103, p  0.29). Thus,
ore distal aortic regions were associated with relatively
arger reductions in aortic distensibility.
FTERWEIGHT LOSS AND CONTINUEDOBESITY. There was
n increase in aortic distensibility at all 3 levels of the aorta
fter weight loss (pooled analysis of both groups), with the
reatest improvement seen in the abdominal section (Fig.
B). Aortic distensibility was unchanged before and after 1
ear of continued obesity (Fig. 5C).
IET VERSUS SURGERY. Improvements in abdominal aortic
istensibility were seen in both the dietary and surgical
ohort (Figs. 5A and 5B). The surgical group also had
ignificant improvements in the proximal descending aortic
istensibility. Distensibility improvements of the ascending
orta did not reach statistical significance for either weight
oss group alone, likely because of smaller numbers per
roup compared with the pooled analysis (Figs. 5A and 5B).
hen normalized to percentage excess weight loss, there
as no difference between the distensibility improvements
een with diet and surgery (Table 3). Of note, pulse pressure
Figure 3 Beneficial Effect of Weight Loss
Pooled analysis for both dietary and surgical weight loss: (A) left ventricular diasto
weight loss; black solid line  normal weight); and (B) aortic distensibility (white bars
loss). NS  not significant.as not significantly altered after weight loss in either of the leight loss groups (diet group 42 vs. 42 mm Hg, p  0.52;
ariatric group 45 vs. 43 mm Hg, p  0.56).
iscussion
lthough significant weight loss in the setting of obesity
omplicated by diabetes has recently been shown to be
ssociated with a reduced myocardial triglyceride content,
mproved hemoglobin A1c, and improved diastolic heart
unction (15), this study is the first to demonstrate a
eneficial effect of significant weight loss per se, in the
bsence of additional identifiable cardiac risk factors, on
entricular structure, myocardial relaxation, and aortic elas-
ic function without the obscuring effects of weight loss on
besity-related comorbidities. Furthermore, we demon-
trate that surgical and dietary weight loss appear to have
imilar beneficial effects. Thus, these findings demonstrate a
echanism that is likely to contribute to the reduction in
ortality rates seen with significant weight loss.
entricular structure. Left and right ventricular hypertro-
hy and cavity dilation in obesity result from a combination
f increased blood volume and (2,16) altered hormonal
ilieu, including hyperleptinemia (17,18), hyperinsulinemia
19), and activation of the renin-angiotensin system (20). In
ur study, on multivariate analysis, BMI and end-diastolic
olume were the 2 main mechanisms by which weight loss
auses LV mass regression. In addition, both visceral fat
ass and leptin change were associated on linear regression.
hus, the reduction in ventricular mass and cavity size most
ction (red solid line  obese after weight loss; blue dashed line  obese before
rmal weight; blue bars  obese before weight loss; red bars  obese after weightlic fun
 noikely results from a combined effect due to the partial
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Cardiovascular Effects of Weight Loss in Obesity August 18, 2009:718–26eversal of the volumetric changes, a reduction in body mass,
nd the improved hormonal milieu. BMI and end-diastolic
olume were independent predictors of LV mass regression
n multivariate analysis, which may indicate that volumetric
nd load changes have a greater influence on LV mass
egression than hormonal changes.
However, despite the improvements in LV structure, the
V mass/end-diastolic volume ratios remained unchanged
nd elevated after weight loss, suggesting a persistent
emodeling abnormality. That finding may be explained by
he relatively short 1-year follow-up period and by the obese
ubjects remaining in the obese BMI range even after
eight loss. Longer-term studies will be needed to investi-
ate whether LV remodeling is completely reversible with
ull weight normalization.
We showed that the RV hypertrophy regression appears
o be greater than that of the LV. That may be a result of
ifferential expression of leptin receptors within the myo-
ardium, with higher levels of expression reported for the
V (21).
ortic elastic function. We demonstrated significant im-
rovement in aortic elastic function with weight loss. Aortic
istensibility changes in obesity have been attributed to
yperleptinemia (22), physical compression from fat (23),
levated inflammatory cytokines (24), and elevated free fatty
cid levels (25).
To rule out external compression from fat as a factor that
mproves abdominal aortic distensibility after weight loss,
e simulated the effect of external compression in an
dditional 6 normal weight, healthy volunteers who under-
ent aortic MR imaging before and after the placement of
10-kg weight on the abdomen (10 kg was chosen as the
bese cohort was on average 44 kg heavier, and it was
stimated that 25% of this weight was abdominal). There
as no change in aortic distensibility at any level (e.g., distal
escending aorta 7.6  2.3 mm Hg1  103 without
eight vs. 8.7  2.4 mm Hg1  103 with weight,
 0.36). Thus, there was no effect of external compression
n aortic elastic function. This finding clearly suggests that
hysical compression of the aorta by excess subcutaneous fat
s neither the mechanism by which obesity mediates aortic
tiffness nor the mechanism by which weight loss improves
ortic distensibility. Furthermore, the cholesterol profile
emained unchanged and cannot be a contributing factor.
hus, it is likely that a decrease in visceral and subcutaneous
at mass with resulting reduction of both leptin and low-
rade inflammation (C-reactive protein) are mediators con-
ributing to this improvement in aortic function.
iastolic dysfunction. Diastolic dysfunction is well recog-
ized in obesity and has been attributed to LV hypertrophy
26). Our data suggest that weight loss results in both
mproved diastolic function and reduced LV mass, suggest-
ng that the LV hypertrophic response may be at least partly
esponsible for the diastolic dysfunction seen in obesity and
V hypertrophy regression for the improvement in diastolicFigure 4 Diastolic Dysfunction
Mean filling curves for (A) dietary weight loss, (B) bariatric surgery, and (C)
continued obesity. Black solid lines indicate normal weight; blue solid lines
indicate obese before weight loss; red dotted lines indicate obese after weight
loss. *p  0.05. NS indicates not significant (p  0.05).unction with weight loss.
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August 18, 2009:718–26 Cardiovascular Effects of Weight Loss in Obesityomparison of bariatric and dietary weight loss. To our
nowledge, this is the first study investigating the relative
enefits of surgical versus dietary weight loss on cardiovas-
ular structure and function. Our data indicate that, when
elated to the degree of excess weight loss, diet and surgery
esult in similar beneficial improvements. Thus, it is the
eduction in fat mass that is important to ameliorating the
aladaptive ventricular hypertrophy and vascular stiffness in
besity and not the mode by which this is achieved.
Although diastolic dysfunction was greater in the surgical
ohort before weight loss, as would be expected from the
igher BMI, the relative improvement in diastole achieved
ith weight loss was the same as that achieved by the dietary
ohort. Again, this finding highlights that the beneficial effects
f weight loss are independent of the mode of weight loss.
onclusions
n obesity per se, in the absence of traditional risk factors,
ignificant weight loss irrespective of mode over a period of
year is associated with partial resolution of abnormal
ardiovascular changes. It is likely that these beneficial
ffects are at least partially responsible for the reduced
ortality seen with weight loss. Thus, obese persons who
re able to achieve this, by whichever modality, are likely to
rofit from these beneficial cardiovascular effects.
eprint requests and correspondence: Dr. Stefan Neubauer, De-
artment of Cardiovascular Medicine, John Radcliffe Hospital, Ox-
ord OX3 9DU, United Kingdom. E-mail: stefan.neubauer@
ardiov.ox.ac.uk.
Figure 5 Aortic Elastic Function
(A) Dietary weight loss, (B) bariatric surgery, and (C) continued obesity. Open bar
*p  0.05. NS indicates not significant (p  0.05). AO  ascending aorta; DDA EFERENCES
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